JP Patent

JP7649257B2 — ハンチントン病を処置するための化合物

Assigned to ピーティーシー セラピューティクス， インコーポレイテッド · Expires 2025-03-19 · 1y expired

What this patent protects

Patent listed against Evrysdi.

Drugs covered by this patent

Patent Metadata

Patent number
JP7649257B2
Jurisdiction
JP
Classification
—
Expires
2025-03-19
Drug substance claim
No
Drug product claim
No
Assignee
ピーティーシー セラピューティクス， インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.